Local 12: Trial looks at treating pneumonia associated with COVID-19
Study examines anti-viral medication that could help reduce common complication of the coronavirus
A breakthrough trial is looking at a new anti-viral medication that could help reduce one of the most common complications of the COVID-19 coronavirus: pneumonia.
This new trial is one of a handful across the country looking at an antiviral therapy intended to stop the spread of this virus.
A team at the University of Cincinnati is conducting this research. Brett Kissela, MD, senior associate dean of clinical research at the UC College of Medicine and UC Health physician, is featured.
Read more about UC-led clinical trials.
Featured photo/Colleen Kelley/UC Creative + Brand
Related Stories
Still the top ‘cat
October 20, 2026
The University of Cincinnati Bearcat mascot was voted Cincinnati’s favorite mascot in a Cincinnati Enquirer reader poll, earning 45.1% of the vote and topping other local favorites.
How will Ohio's minimum wage bump impact businesses and their employees?
October 20, 2026
UC economist Michael Jones spoke to WVXU's "Cincinnati Edition" on if Ohio's latest minimum wage increase will actually impact employees and businesses as inflation continues to rise.
Researchers test gene therapy as less invasive treatment for hydrocephalus
October 20, 2026
Researchers at the University of Cincinnati College of Medicine say an experimental gene therapy could eventually lead to a less invasive treatment for hydrocephalus, a condition in which excess fluid accumulates in the brain. The early-stage study, led by Agnes (Yu) Luo, PhD, professor and vice chair for research, was published in the journal Fluids and Barriers of the CNS. Yahoo! News recently featured it.